Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Marcin Balcerzak"'
Autor:
Piotr Merks, Jameason D. Cameron, Marcin Balcerzak, Urszula Religioni, Damian Świeczkowski, Mikołaj Konstanty, Dagmara Hering, Filip M. Szymański, Milosz Jaguszewski, Régis Vaillancourt
Publikováno v:
BMC Primary Care, Vol 23, Iss 1, Pp 1-8 (2022)
Abstract Backround Dabigatran is a direct thrombin inhibitor used to treat cardiac arrhythmias, and rates of non-adherence to dabigatran in Polish populations are high. The current study examined how a pharmacist-led intervention of counselling with
Externí odkaz:
https://doaj.org/article/2e6d5ff47c854e97b6c18b67ded715f1
Autor:
Adam Antczak, Aneta Nitsch-Osuch, Marcin Balcerzak, Michał Byliniak, Joanna Chorostowska-Wynimko, Karina Jahnz-Różyk, Mikołaj Konstanty, Jarosław Krzywański, Ernest Kuchar, Agnieszka Mastalerz-Migas, Marek Wójcik, Leszek Szenborn
Publikováno v:
Vaccines, Vol 10, Iss 12, p 2030 (2022)
In 2022, the National Program for Influenza Prevention coalition will have its 10th anniversary; it is one of Poland’s oldest educational initiatives. The National Program for Influenza Prevention was initiated to prevent a further decline and prom
Externí odkaz:
https://doaj.org/article/2ffb545e0d7e48dc9a7e01beb65feb58
Publikováno v:
Investigative and Clinical Urology, Vol 60, Iss 2, Pp 114-119 (2019)
Purpose: Mirabegron, a β3-adrenoreceptor agonist, is used to treat overactive bladder. The factors affecting persistence of mirabegron use or symptom improvement are not thoroughly known, but could be related to patient characteristics. Therefore, w
Externí odkaz:
https://doaj.org/article/d407755468fc405bb76da4cba591e8ee
Autor:
Piotr Koprowski, Wojciech Grajkowski, Marcin Balcerzak, Iwona Filipiuk, Hanna Fabczak, Andrzej Kubalski
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0127029 (2015)
Bacterial mechano-sensitive (MS) channels reside in the inner membrane and are considered to act as emergency valves whose role is to lower cell turgor when bacteria enter hypo-osmotic environments. However, there is emerging evidence that members of
Externí odkaz:
https://doaj.org/article/0db9237e7c7e481ea14338380377234b
Autor:
Marek Jarecki, Pawel Paczkowski, Marek Krawczyk, Cezary Pszenny, Bozena Haznar, Marcin Balcerzak, Jan Pachecka, Grazyna Kubiak-Tomaszewska, Piotr Tomaszewski
Publikováno v:
Molecules, Vol 8, Iss 1, Pp 146-152 (2003)
Arterial ketone body ratio (AKBR), which reflects hepatic intramitochodrial redox potential, was measured in 20 patients with Carcinoma hepatis metastaticum and good circulatory condition (group A), and 16 patients with Carcinoma hepatis metastaticum
Externí odkaz:
https://doaj.org/article/4c14c5ada3f8401b8c5fc65c4b8aa568
Autor:
Marcin Balcerzak, Miłosz Jaguszewski, Dagmara Hering, Jerzy Krysiński, Piotr Merks, Ewelina Drelich, Urszula Religioni, Damian Świeczkowski
Publikováno v:
Cardiology Journal
Background Pharmaceutical pictograms have been designed to help communicate medication instructions to patients. Pictograms used within a patient counseling service can significantly improve medication compliance and adherence. The study aimed to ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21ae475f8d215d10a0649618585a78f5
http://europepmc.org/articles/PMC8747827
http://europepmc.org/articles/PMC8747827
Autor:
Natalia Cwalina, Jerzy Krysiński, Damian Świeczkowski, Szymon Zdanowski, Ewelina Drelich, Piotr Merks, Katarzyna Białoszewska, Grażyna Gromadzka, Marcin Balcerzak, Miłosz Jaguszewski
Publikováno v:
Patient Preference and Adherence. 13:1667-1676
Purpose To evaluate the practical utility of pharmaceutical pictograms in routine practice in community pharmacy. The primary outcome (composite endpoint) consisted of three elements: i) complete use of the whole package of medication, ii) taking the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32b76629f3842715cdb26340402ec85f
https://doi.org/10.2147/ppa.s214419
https://doi.org/10.2147/ppa.s214419
Autor:
Marcin Balcerzak, Grzegorz Juszczyk, Adam Antczak, Piotr Merks, Régis Vaillancourt, Mariola Drozd, Marcin Czech, Michal Byliniak, Urszula Religioni, Elżbieta Piotrowska-Rutkowska
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 17, Iss 7945, p 7945 (2020)
International Journal of Environmental Research and Public Health
International Journal of Environmental Research and Public Health
The phenomenon of population ageing observed over recent years involves growing healthcare needs and the limited staffing and financing of healthcare systems, and as such demands some functional changes in the healthcare model in many countries. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03ab4eaee815b5f6cb284ffb0d5e99ab
https://www.mdpi.com/1660-4601/17/21/7945
https://www.mdpi.com/1660-4601/17/21/7945
Autor:
Natalia Cwalina, Régis Vaillancourt, Piotr Merks, Ewelina Drelich, Annie Pouliot, Marcin Balcerzak, Miłosz Jaguszewski, Katarzyna Białoszewska, Jerzy Krysiński, Damian Świeczkowski
Publikováno v:
Patient preference and adherence
Piotr Merks,1,2,* Damian Åwieczkowski,3,* Marcin Balcerzak,4 Ewelina Drelich,4 Katarzyna BiaÅoszewska,5 Natalia Cwalina,3 Jerzy Krysinski,1 MiÅosz Jaguszewski,3 Annie Pouliot,6 Regis Vaillancourt6 1Department of Pharmaceutical Technology, Co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2254182e6982193cc66b1fdaccc3a07f
http://europepmc.org/articles/PMC5818874
http://europepmc.org/articles/PMC5818874
Publikováno v:
Investigative and Clinical Urology
Investigative and Clinical Urology, Vol 60, Iss 2, Pp 114-119 (2019)
Investigative and Clinical Urology, Vol 60, Iss 2, Pp 114-119 (2019)
Purpose: Mirabegron, a β3-adrenoreceptor agonist, is used to treat overactive bladder. The factors affecting persistence of mirabegron use or symptom improvement are not thoroughly known, but could be related to patient characteristics. Therefore, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74df264512f0983b24d0022d1fd4ef01
https://doi.org/10.4111/icu.2019.60.2.114
https://doi.org/10.4111/icu.2019.60.2.114